glutathione and chronic kidney disease is an aging-related metabolic signature in the mouse is glutathione bad for kidneys

BPC-157 appears in FDA's nominated-but-withdrawn table for bulk compounding substances, with FDA citing immunogenicity and impurity concerns

And so we're gonna take a little bit of a dive into BPC 157

Well start with the seven peptides that the FDAs Pharmacy Compounding Advisory Committee considered at the July, 2026 meeting

Unreconstituted powder lasts much longer than reconstituted solution

Other ingredients are used to maintain the stability of formulation

Some areas of interest for this peptide include increasing insulin sensitivity, nerve pain, and heart, and cardiovascular disease among a few of the disease processes noted